Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

adenosine deaminase-deficient severe combined immunodeficiency

(uh-DEH-nuh-seen dee-A-mih-nays-deh-FIH-shunt seh-VEER kum-BIND IH-myoo-noh-deh-FIH-shun-see)
A rare, inherited disorder in which the immune system is damaged, causing a person to have a complete lack of B lymphocytes and T lymphocytes (types of white blood cells that help the body fight infection). People with adenosine deaminase-deficient severe combined immunodeficiency are at high risk of developing life-threatening viral, bacterial, and fungal infections and certain types of cancers. Signs and symptoms of adenosine deaminase-deficient severe combined immunodeficiency usually occur before 6 months of age and include serious lung infections, chronic diarrhea, skin rashes, and slow growth and development. When symptoms begin later in life, they are usually milder. Adenosine deaminase-deficient severe combined immunodeficiency is caused by mutations (changes) in the ADA gene. The ADA gene makes an enzyme called adenosine deaminase, which helps protect lymphocytes from harmful substances in the body. Also called ADA-SCID.
Search NCI's Dictionary of Cancer Terms